DHA R&D-MRDC researchers are applying the latest regulatory guidance related to AI to better carry out their mission to develop life-saving medicines.

GenAI offers a realistic path forward in tackling previously undruggable targets, with the potential to reshape the entire ...

Pakistan’s pharma sector is increasingly deploying artificial intelligence (AI) and advanced technologies to improve drug ...

Google DeepMind CEO Demis Hassabis, one of the only people in the world with a Nobel Prize for work on artificial ...

As per Vantage Market Research, the Global Artificial Intelligence in the Drug Discovery Market has been steadily growing over the years due to the growing demand for personalized medicine, the ...

At Google DeepMind, researchers are chasing what's called artificial general intelligence: a silicon intellect as versatile ...

The global AI-enabled drug discovery and clinical trials market size is estimated to reach USD 1,599 by 2030 from 2019 with a CAGR of 24%. The clinical guidelines are not uniform across the studied ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to ...

Artificial intelligence (AI) is taking over the world. The U.S. Food and Drug Administration (FDA) recently announced it ...

Artificial Intelligence In Precision Medicine Market AI accelerates the drug discovery process by analyzing complex biological data to iden ...

Many AI companies, particularly those in early development ... “AI in Drug Discovery and Its Clinical Relevance.” McKinsey and Company. “Artificial Intelligence—Automotive’s New Value ...